unresectable breast carcinoma
Showing 1 - 6 of 6
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jan 31, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,
Withdrawn
- Triple Negative Breast Cancer
- +4 more
- Nab-paclitaxel
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 2, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Suspended
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Copanlisib Hydrochloride
- Eribulin Mesylate
-
Gainesville, Florida
- +10 more
Nov 16, 2022
Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,
Recruiting
- Breast Adenocarcinoma
- +8 more
- Atezolizumab
- +6 more
-
Birmingham, Alabama
- +667 more
Apr 6, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +51 more
- Dostarlimab
- Niraparib
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 15, 2022